Literature DB >> 19482011

Trace amine-associated receptor 1 as a monoaminergic modulator in brain.

Zhihua Xie1, Gregory M Miller.   

Abstract

Brain monoaminergic systems play critical roles in mood, cognition, emotion, reward, learning and attention, and aberrance in brain monoaminergic activity is associated with a variety of neuropsychiatric disorders/diseases. The present commentary focuses on trace amine-associated receptor 1 (TAAR1) and its potential regulatory roles in brain monoaminergic systems. TAAR1 was discovered in 2001 and has been established to be a G-protein-coupled receptor signaling through the cAMP pathway. This receptor is activated by a broad spectrum of agonists, although there are notable species differences in ligand efficacy and potency. TAAR1 is expressed and widely distributed in brain monoaminergic systems and co-localized with the dopamine transporter in a subset of dopaminergic neurons in rhesus monkey and mouse brain substantia nigra. TAAR1 activation by the common biogenic amines, the trace amine beta-phenylethylamine and methamphetamine alters the monoamine transporter function in both mouse and rhesus monkey brain synaptosomes, suggesting a modulatory role for this receptor in the presynaptic regulation of monoaminergic activity. However, little is known about other functional roles of TAAR1 in the brain. With a purpose to promote further studies on this receptor, we herein discuss the recent findings that provide insights into the functional significance and biological relevance of this receptor as a modulator in brain monoaminergic systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482011      PMCID: PMC2748138          DOI: 10.1016/j.bcp.2009.05.031

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  75 in total

Review 1.  Role of dopamine in the motivational and cognitive control of behavior.

Authors:  Roshan Cools
Journal:  Neuroscientist       Date:  2008-08       Impact factor: 7.519

2.  Modulatory effects of serotonin on GABAergic synaptic transmission and membrane properties in the deep cerebellar nuclei.

Authors:  Fumihito Saitow; Mitsumasa Murano; Hidenori Suzuki
Journal:  J Neurophysiol       Date:  2009-01-14       Impact factor: 2.714

3.  Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.

Authors:  Mark A Cervinski; James D Foster; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2005-10-04       Impact factor: 5.157

4.  Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.

Authors:  L'aurelle A Johnson; Cheryse A Furman; Minjia Zhang; Bipasha Guptaroy; Margaret E Gnegy
Journal:  Neuropharmacology       Date:  2005-10-05       Impact factor: 5.250

5.  Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients.

Authors:  G J E Schmitt; T Frodl; S Dresel; C la Fougère; R Bottlender; N Koutsouleris; K Hahn; H-J Möller; E M Meisenzahl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-11-15       Impact factor: 5.270

6.  Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues.

Authors:  Matthew E Hart; Katherine L Suchland; Motonori Miyakawa; James R Bunzow; David K Grandy; Thomas S Scanlan
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

7.  Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association.

Authors:  Zhihua Xie; Eric J Vallender; Naichen Yu; Shelli L Kirstein; Hong Yang; Mary E Bahn; Susan V Westmoreland; Gregory M Miller
Journal:  J Neurosci Res       Date:  2008-11-15       Impact factor: 4.164

8.  Imaging serotonin transporters using [123I]ADAM SPECT in a parkinsonian primate model.

Authors:  Kuo-Hsing Ma; Wen-Sheng Huang; San-Yuan Huang; Cheng-Yi Cheng; Ching-Yuan Chen; Lie-Hang Shen; Jiang-Chuan Liu; Ying-Kai Fu
Journal:  Appl Radiat Isot       Date:  2008-06-28       Impact factor: 1.513

Review 9.  Noradrenaline involvement in basic and higher integrated REM sleep processes.

Authors:  Claude Gottesmann
Journal:  Prog Neurobiol       Date:  2008-04-22       Impact factor: 11.685

10.  PET demonstrates reduced dopamine transporter expression in PD with dyskinesias.

Authors:  A R Troiano; R de la Fuente-Fernandez; V Sossi; M Schulzer; E Mak; T J Ruth; A J Stoessl
Journal:  Neurology       Date:  2008-11-19       Impact factor: 9.910

View more
  32 in total

1.  Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1.

Authors:  Cindy Achat-Mendes; Laurie J Lynch; Katherine A Sullivan; Eric J Vallender; Gregory M Miller
Journal:  Pharmacol Biochem Behav       Date:  2011-11-04       Impact factor: 3.533

2.  Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1).

Authors:  Gregory M Miller
Journal:  J Med Chem       Date:  2012-01-20       Impact factor: 7.446

Review 3.  The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity.

Authors:  Gregory M Miller
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

4.  The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats.

Authors:  David A Thorn; Chaogui Zhang; Yanan Zhang; Jun-Xu Li
Journal:  Neurosci Lett       Date:  2014-02-21       Impact factor: 3.046

5.  Differential genetic risk for methamphetamine intake confers differential sensitivity to the temperature-altering effects of other addictive drugs.

Authors:  John R K Mootz; Nicholas B Miner; Tamara J Phillips
Journal:  Genes Brain Behav       Date:  2020-01-15       Impact factor: 3.449

6.  Trace amines and cocaine abuse.

Authors:  Jun-Xu Li
Journal:  ACS Chem Neurosci       Date:  2014-05-21       Impact factor: 4.418

7.  Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells.

Authors:  Ada Ledonne; Mauro Federici; Michela Giustizieri; Mauro Pessia; Paola Imbrici; Mark J Millan; Giorgio Bernardi; Nicola B Mercuri
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

8.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 9.  Tako-tsubo cardiomyopathy: how to understand possible pathophysiological mechanism and the role of (123)I-MIBG imaging.

Authors:  Derk O Verschure; G Aernout Somsen; Berthe L F van Eck-Smit; Remco J J Knol; Jan Booij; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2014-01-25       Impact factor: 5.952

10.  Functional evolution of the trace amine associated receptors in mammals and the loss of TAAR1 in dogs.

Authors:  Eric J Vallender; Zhihua Xie; Susan V Westmoreland; Gregory M Miller
Journal:  BMC Evol Biol       Date:  2010-02-18       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.